Thursday, January 22, 2026
Home Authors Posts by Ogkologos

Ogkologos

4117 POSTS 0 COMMENTS

Sevabertinib Shows Antitumour Activity in Patients with Locally Advanced or Metastatic...

Ogkologos -
0

FDA Approves Daratumumab and Hyaluronidase-fihj for High-Risk Smoldering Multiple Myeloma

Ogkologos -
0

EMA Recommends Extending Indications for Lisocabtagene Maraleucel

Ogkologos -
0

ESMO Launches First Congress on Artificial Intelligence and Digital Oncology: A...

Ogkologos -
0

Presence of Tumour and Higher Levels of LAG3-positive T-cells in the...

Ogkologos -
0

ESMO Calls for Cancer Care Safeguards in the EU’s Health Crisis...

Ogkologos -
0

PROs Support Switching to Camizestrant Plus CDK4/6 Inhibitor for HR-positive, HER2-negative...

Ogkologos -
0

Rucaparib Monotherapy Provides Significant and Durable Long-Term Benefit as First-Line Maintenance...

Ogkologos -
0

FDA Approves Belantamab Mafodotin-blmf for Relapsed or Refractory Multiple Myeloma

Ogkologos -
0

Long-Term Follow-Up Data Support Longer RFS with Adjuvant Nivolumab Than with...

Ogkologos -
0
1...567...412Page 6 of 412

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com